Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2012 | 07-2012 | 04-2012 | 01-2012 | 10-2011 | |
| Sales | 524 | 278 | 0 | 151 | 106 |
| Cost of Goods | 9 | 6 | N/A | 3 | 11 |
| Gross Profit | 515 | 272 | N/A | 148 | 95 |
| Operating Expenses | 1,207 | 1,953 | 0 | 2,025 | 2,160 |
| Operating Income | -683 | -1,675 | N/A | -1,874 | -2,054 |
| Interest Expense | 868 | 1,926 | 0 | 5,342 | 872 |
| Other Income | 7 | 15 | 0 | -83 | -4 |
| Pre-tax Income | -1,544 | -3,587 | 0 | -7,299 | -2,930 |
| Net Income Continuous | -1,544 | -3,587 | N/A | -7,299 | -2,930 |
| Net Income | $-1,557 | $-3,587 | $N/A | $-7,299 | $-2,930 |
| EPS Basic Total Ops | -31,040.00 | -76,160.00 | N/A | -0.26 | -0.12 |
| EPS Basic Continuous Ops | -30,792.14 | -76,056.55 | N/A | -0.26 | -0.09 |
| EPS Diluted Total Ops | -84,160.00 | -137,600.00 | N/A | -0.39 | -0.29 |
| EPS Diluted Continuous Ops | -28,849.64 | -70,932.84 | N/A | -0.25 | -0.09 |
| EBITDA(a) | $-517 | $-1,675 | $N/A | $-1,708 | $-640 |